Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

IL-12 p40 GENE EXPRESSION: INHIBITORY PATHWAYS AND INFLAMMATORY BOWEL DISEASE

Rao, Kavitha N (2006) IL-12 p40 GENE EXPRESSION: INHIBITORY PATHWAYS AND INFLAMMATORY BOWEL DISEASE. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

[img]
Preview
PDF
Primary Text

Download (5MB) | Preview

Abstract

The IL-12 family of heterodimeric cytokines, comprising IL-12, IL-23 and IL-27, is an integral component of the inflammatory response. The IL-12 p40 subunit, which is part of both IL-12 and IL-23, is expressed specifically in macrophages and dendritic cells in response to microbial stimuli which signal through toll-like receptors (TLRs) and nucleotide-oligomerization-binding domain (NOD) proteins. Dysregulated expression of IL-12 p40 could lead to prolonged, unresolved inflammation manifesting into chronic inflammatory disorders such as inflammatory bowel disease (IBD). Understandably, IL-12 p40 expression is tightly regulated. We have demonstrated the requirement of a complex comprising nuclear factor of activated T cells (NFAT) and interferon regulatory factor 8 (IRF8) in IL-12 p40 gene transcriptional regulation. Subsequently, IRF8 was shown to be a target for an important anti-inflammatory pathway activated by carbon monoxide (CO) and heme oxygenase-1 (HO-1) in murine IBD. This dissertation explored two molecular mechanisms of IL-12 p40 inhibition - targeting the transcription factor NFAT using a novel cell-permeable inhibitory peptide and phosphoinositide 3-kinase (PI3K) mediated inhibition of IL-12. Firstly, VIVIT peptide which prevents the nuclear translocation of NFAT was employed to examine the role of NFAT in macrophage gene expression. We observed that NFAT inhibition attenuated the expression of inflammatory cytokines including IL-12, IL-23 and TNF. Secondly, we studied PI3K mediated inhibition of IL-12 and characterized immune responses and macrophage defects in PI3K p110δ mutant mice which spontaneously develop IBD. We observed that the PI3K mutant mice recapitulate certain aspects of human IBD, including a profound increase in several proinflammatory cytokines in the intestinal mucosa and in macrophages, such as IL-12, IL-23, IL-17, TNF and IFN-γ. Furthermore, macrophages from PI3K p110δ mutant mice were defective in IL-10 and C5a mediated inhibition of IL-12 p40.Thus, the expression of proinflammatory cytokines is coordinately regulated by transcription factors (such as NFAT and IRF8) and signaling molecules (such as PI3K), and mechanisms limiting inflammation are crucial for maintenance of immune homeostasis. Manipulation of such inhibitory pathways is a potential therapeutic approach for treating chronic inflammatory disorders.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: University of Pittsburgh ETD
Status: Unpublished
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Rao, Kavitha Nknr8@pitt.eduKNR8
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Committee ChairPlevy, Scottsplevy@med.unc.edu
Committee MemberRay, Anuradharaya@pitt.eduRAYA
Committee MemberLu, Binfengbinfeng@pitt.eduBINFENG
Committee MemberKane, Lawrencelkane@pitt.eduLKANE
Committee MemberMorris, Sidneysmorris@pitt.eduSMORRIS
Date: 17 August 2006
Date Type: Completion
Defense Date: 31 July 2006
Approval Date: 17 August 2006
Submission Date: 15 August 2006
Access Restriction: No restriction; Release the ETD for access worldwide immediately.
Institution: University of Pittsburgh
Schools and Programs: School of Medicine > Immunology
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: IBD; IL-12; inflammation; IRF8; NFAT; PI3-kinase
Other ID: http://etd.library.pitt.edu/ETD/available/etd-08152006-171506/, etd-08152006-171506
Date Deposited: 10 Nov 2011 19:59
Last Modified: 15 Nov 2016 13:49
URI: http://d-scholarship.pitt.edu/id/eprint/9106

Metrics

Monthly Views for the past 3 years

Plum Analytics


Actions (login required)

View Item View Item